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Introduction
Recently, we published a study demonstrating that a 
deletion of the gene p21CIP/WAF converts a non-regener-
ating strain of mouse to one capable of epimorphic 
regeneration and has provided a unique opportunity to 
uncover some of the unknowns of this process in 
mammals. Since p21 is involved intricately in so many 
cellular processes, it is not clear at this time how deletion 
of this gene results in such a healing phenotype. Th  is 
review will discuss our results, how our ﬁ  ndings relate to 
other studies, and speculation as to the role of p21 in 
regeneration.
A mammalian model of regeneration, the MRL 
mouse
In 1998, the MRL (Murphy Roths Large) mouse, 
generated from cross-breeding AKR, C3H, C57BL/6(B6), 
and LG strains of mice [1], was shown to be able to close 
ear punches without showing residual signs of injury or 
scarring [2]. Multiple tissues were perfectly replaced, 
cartilage re-grew, and hair follicles reappeared. Further-
more, this type of perfect multi-tissue healing, known as 
epimorphic regeneration, occurred with the formation of 
a blastema-like structure that had been shown to be key 
to amphibian limb regeneration [3-5]. Th  is  phenomenon 
had earlier been seen in rabbit ear holes [6-8], and 
furthermore, a blastema-derived structure had also been 
described during antler re-growth [9]. Th  e amphibian 
and mammalian ear hole regeneration processes have 
many features in common, including rapid re-
epithelialization of the wound [2], elimination of the 
basement membrane between the epidermal and dermal 
tissue layers [10,11], blastema formation, re-growth of 
cartilage and hair follicles, and scarless healing [2,12,13]. 
However, the existence of an inbred mouse model 
allowed this process to be genetically approachable. It 
was also determined that one of the strains used to 
generate the MRL mouse, the LG/J mouse, contributed 
the regeneration phenotype [14].
Ear hole closure has lent itself exceedingly well to 
genetic studies as this is a wound that is easy to access 
and measure and has proven to be a highly quantitative 
trait [15-17]. Recently, making use of an advanced 
intercross line (LG, SM F34 AIL) employing 1,200 mice 
and 3,600 single nucleotide polymorphisms [18], 18 
quantitative trait loci were identiﬁ  ed for ear hole closure 
with small intervals from 0.661 to 7.141 Mb in length, 
which essentially reduced the healing intervals 10- to 
50-fold from studies using F2 mice [15] (JM Cheverud et 
al., manuscript in preparation). Th   is has allowed a more 
focused analysis of candidate genes. Further narrowing of 
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should lead to the ﬁ  nal identiﬁ  cation of these genes.
Besides ear hole closure, multiple organ and injury 
systems have extended the MRL mouse’s unusual healing 
properties. Th   ey include regenerative studies in the heart 
[19-21], central nervous system stem cells and tissue 
[22-24], cartilage [25], cornea [26], digit [27,28] and myo-
metrial healing [29]. Dorsal skin wound healing, which 
involves skin contracture, has been reported to be no 
diﬀ  erent or even worse in the MRL compared to controls 
[30,31]. However, a recent study shows that if the wound 
has a syngeneic or allogenic skin transplant, the MRL 
shows far better healing than the control [32]. One 
possible explanation for the healing diﬀ  erences  in 
diﬀ   erent systems is that wound contracture, involving 
myoﬁ  broblasts or cells expressing Sma-1 (smooth muscle 
actin), known to be responsible for scarring, is diﬀ  erent 
in the MRL. Preliminary studies suggest this [33] (D 
Gourevitch, K Bedelbaeva, unpublished data). Th  us,  the 
wound site and type of wound need to be considered in 
the MRL’s healing properties.
G2/M cell cycle accumulation of regenerating cells
Th   e cells derived from the ear of regenerating and non-
regenerating mice also show signiﬁ  cant diﬀ  erences from 
each other and represent what is seen in vivo. MRL 
ﬁ   broblast-like cells from uninjured ears display an 
uncommon metabolic proﬁ   le characteristic of an 
embryonic-type aerobic glycolysis, a feature of the adult 
MRL mouse itself, versus the more common metabolic 
state - oxidative phosphorylation - as seen in the B6 
mouse [34]. Th   ese cells express stem cell markers similar 
to adult MRL tissue that expresses these markers [34]. In 
a separate study, cells derived from the injured MRL ear 
blastema expressed stem cell markers as found in vivo 
[35] and displayed highly proliferative and migratory 
responses  in vitro similar to human multipotential 
progenitor cells in this study [36].
Th  e rapid growth rate of ﬁ  broblast-like cells from the 
uninjured MRL ear was noted early on and examination 
of cell cycle regulation comparing healer MRL to non-
healer B6 cells showed that the healer cells had an 
unusual accumulation of cells in G2/M [33]. A likely 
explanation of such G2/M accumulation or potential 
arrest was a DNA damage response and this was 
supported by an increased p53 response in the MRL [33] 
and conﬁ  rmed with data showing that foci of γH2AX and 
TopBP1, a phosphorylated histone and a protein re-
cruited to sites of DNA damage, respectively, were highly 
increased in MRL cells and tissue [33]. DNA damage 
itself was tested using the comet assay and found in 
nearly 90% of healer cells compared to 5% of non-healer 
cells, showing both single-strand and double-strand 
breaks. Furthermore, the DNA repair protein RAD51 
was increased in healer cells, suggesting that error-free 
homologous recombination was being used [33]. Th  e 
cause of the DNA damage is still unclear, but the lack of 
the cell cycle protein p21Cip1/Waf1 discussed below suggests 
a replicative stress mechanism.
Th   ese results agree with many reports in the literature 
that G2/M accumulation is associated with regeneration 
in examples ranging from hydra [37] to amphibian [38] to 
mammalian liver [39,40]. Th  e literature also shows that 
cells undergoing blastema formation synthesize DNA but 
have a low mitotic index, indicating an accumulation 
between S and M and implicating G2 [41-47]. Multiple in 
vitro studies have carefully explored cell cycle arrest and 
the factors involved in the re-entry of cells into S phase of 
the cell cycle and accumulation in G2, as seen in 
multinucleated muscle myotubes and myoﬁ  bers  from 
regenerating amphibian limbs [48], in multinucleated 
mammalian myotubes generated from rat C2C12 cell line 
myoblasts, and in primary mouse myoblasts [49-51].
In MRL ear-derived cells, the fact that DNA damage 
was so widespread made one question why an accumu-
lation of cells was seen in G2/M and not in G1/S. Th  is  led 
to an examination of G1 cell cycle regulatory proteins. 
Th  e ﬁ   rst to be examined, the CDKN1A or p21Cip1/Waf1 
protein [52], was found to be repressed in these cultured 
cells. Examination of similar ear-derived cells from a 
CDKN1A-deﬁ   cient mouse [33] showed the same 
phenotype as MRL cells with increased DNA damage, 
γH2AX expression, and G2/M accumulation. But most 
striking was the fact that this mouse could fully close ear-
hole injuries at least as well as the MRL mouse [33]. 
Th  ere have been other mice that possess the ability to 
partially heal ear holes, including nude mice [53], mice 
expressing the transgene AGF (angiopoietin-related 
growth factor) in keratinocytes [54], and mice selected for 
inﬂ  ammatory potential [55]. However, what was surprising 
to us was that deletion of this single gene, as predicted 
from our in vitro ear dermal cell model, could actually 
result in the full MRL epimorphic regeneration phenotype.
The role of p21CIP1/Waf1, regeneration, and the 
retinoblastoma protein
Earlier studies have examined the role of p21 in regenera-
tion of the mammalian liver. Gene expression of p21 
plays a role in hepatic regeneration by both p53-
dependent and p53-independent control mechanisms 
[56]. Transgenic mice that over-express p21 produced 
large polyploid nuclei in a portion of the hepatocytes and 
the regenerative capacity of the livers was halted [57]. 
Over-expression of STAT-3 with resulting p21 upregu-
lation impairs regeneration in fatty livers [58]. Consistent 
with this picture, repression of the p53/p21 pathway was 
shown to enhance liver regeneration [59]. Such studies 
parallel our recent ﬁ  ndings [33].
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quite overwhelming considering the complexity of 
functions in which this protein has been implicated. p21 is 
involved in the response to cellular stresses, such as DNA 
damage, oxidative stress, cytokines, mitogens, tumor 
viruses, and anti-cancer agents, and can have tumor 
suppressive activities and oncogenic capabilities depend-
ing on the cell type and context [60,61]. For example, p21 
is transcriptionally regulated by p53 for tumor suppressor 
activity and as an inhibitor of cell cycle progression 
through the inhibition of cyclin-dependent kinase (CDK)-
cyclin complexes and proliferating cell nuclear antigen, 
which can lead to diﬀ  erentiation, apop  tosis, or senescence. 
Increasing this complexity is the fact that p21 can regulate 
gene expression and other cellular events, such as 
autophagy and a DNA damage repair response, through 
protein-protein interactions that depend on the cell type, 
subcellular localization, expres  sion levels, protein stability, 
and post-translational modiﬁ  cations [62-66].
So which of these functions are involved in the re-
genera  tion phenotype seen in the p21-/- mice? Some 
indication may come from in vitro studies in other re-
generating systems. For example, adult urodele amphi-
bians can regenerate limbs through a process that 
involves loss of diﬀ   erentiation markers, cell cycle re-
entry, proliferation, formation of a blastema, and diﬀ  er-
en  tiation into adult tissue [12]. In an amphibian in vitro 
model of skeletal muscle regeneration, retinoblastoma 
(Rb) protein plays a predominant role in cell cycle re-
entry through phosphorylation by CDK4/6 [67]. Th  is 
process requires serum to stimulate entry of the 
quiescent nuclei of multinuclear myotubes into S-phase 
with a serum-derived thrombin-activated factor being 
necessary for Rb hyperphosphorylation, resulting in its 
‘inactivation’ [48,68]. Th   ese cells enter S phase but arrest 
and do not separate into single cells, which would allow 
further progression of the cell cycle through mitosis. 
However, there are conﬂ  icting reports about mammalian 
cells. Myotubes from an Rb-/- mouse are capable of cell 
cycle re-entry and show DNA synthesis upon serum 
stimulation but no mitosis in one study [50] but no cell 
cycle re-entry in another [51]. In a separate study using 
mammalian myotubes generated from the rat C2C12 
myoblast line, newt regeneration blastema extract led to 
myotube cellularization to smaller myotubes and pro-
liferating mononucleate cells, suggesting de-diﬀ  eren-
tiation with reduced expression of mature muscle cell 
markers [49]. In addition, a recent report using primary 
myoblasts [69] suggests that another factor in addition to 
Rb, p19arf, must be inactivated for cell cycle re-entry and 
de-diﬀ  erentiation in postmitotic mammalian muscle. Th  e 
tumor suppressor protein p19arf acts as a regeneration 
suppressor and is not found in regenerative vertebrates, 
suggesting that it has interesting potential as a key to 
mammalian regeneration. Th   us, Rb inactivation has been 
shown to be important in both amphibian and mam-
malian regeneration in vitro.
Th   e p21 protein, its major role being a CDK inhibitor 
found on chromosome 17 in the mouse, is known to 
block proliferation by preventing the phosphorylation of 
Rb and the transcription of cell cycle-regulated pro-
proliferative proteins. Th  e p21 protein binds to cyclin-
CDK (2/4) complexes, not allowing them to function as 
kinases. Th  ey in turn cannot phosphorylate Rb, which 
remains bound to E2F, a transcription factor responsible 
for proliferation, eﬀ  ectively blocking E2F function. Th  us, 
p21 activity directly leads to suppression of cell cycle 
transit and the loss of p21 should promote E2F activity, 
lead to enhanced DNA synthesis and potentially to de-
diﬀ  erentiation. Rb function, then, in the studies above 
should be directly aﬀ  ected by p21 activity.
Not surprisingly, p53 and p21 have been shown to 
prevent the transition from ﬁ   broblasts to induced 
pluripotent stem cells [70-72]. Th  e level of de-diﬀ  er-
entiation in the p21-/- mouse is being further explored, 
although we have previously reported that stem cell 
markers are over-expressed in MRL tissue [34].
The role of p53, senescence, and transforming 
growth factor-β in regeneration
As mentioned above, we found that p53 was up-regulated 
in MRL mouse ears, though p21 was absent. Is there a 
role for p53 in regeneration? Unlike the p21-/- mouse, 
which is a complete regenerator, p53-/- mice show no 
regenerative capacity [73]. Th  is  ﬁ  nding established a p53-
independent function of p21 that is important for 
regeneration. However, MRL.p53-/- crosses showed not 
only healing rates similar to or better than the MRL itself 
but also showed enhanced diﬀ  erentiation in the form of 
increased chondrogenesis and adipogenesis [73]. Th  e 
major role played by p53 as the ‘guardian’ of the genome 
is due to its ability to respond to DNA damage and 
cellular stress by inhibiting cell cycle progression and 
then regulating DNA repair, cell cycle control, apoptosis, 
diﬀ  erentiation, autophagy induction, and senescence. It is 
not clear which of these functions or lack thereof could 
be responsible for the enhanced diﬀ  erentiation observed 
in MRL.p53-/- mice [64,71,74-79]. One study suggests that 
removal of p53 allows for an accumulation of cells with 
elevated levels of DNA damage (on a repair-deﬁ  cient 
background mouse), which delays hair follicle renewal 
and regeneration [80,81]. However, we observed hair 
follicle formation in our MRL/p53-/- mice [73]. Further 
regeneration studies on diﬀ  erent tissue types need to be 
performed in order to determine the role of p53 in 
regeneration.
One potential area of interest are the roles of p21 and 
p53 in both diﬀ   erentiation and cellular senescence at 
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mouse stem cells with dysfunctional telomeres, a marker 
for senescence induction, increases stem cell function 
and the life span of these mice without an increase in 
cancer formation, providing a direct role for p21 in both 
stem cell diﬀ  erentiation and senescence [82]. One direct 
link for p21 in diﬀ  erentiation and senescence is sup  pres-
sion by the Twist proteins, major regulators of embryo-
genesis [83]. Th  e Twist proteins inhibit p21 in a p53-
independent manner and promote epithelial-mesen-
chymal transition and suppress cellular senescence [84].
Th  e two major pathways for inducing senescence in 
cells of multiple tissues are p53/p21 [85-91] and p16ink4a 
[75,92-95]. In an earlier paper, we suggested that senes-
cence was not a factor in MRL regeneration because of 
the lack of p53 requirement [73]. However, there is, in 
fact, evidence that p21 can induce senescence in the 
absence of p53 [87,96-98] as well as p53-mediated p21-
independent activation of senescence [99-101]. It has 
been suggested that reactive oxygen species are necessary 
to maintain the senescence phenotype and that both p16 
and p21 are involved [99,102,103]. Actually, we previously 
reported that reactive oxygen species levels are decreased 
in the MRL mouse [34], consistent with an aerobic 
glycolytic metabolism, which argues against senescence 
playing a functional role. In addition, the protein RhoD, 
which is required for transformation by the oncogenic 
protein Ras, is responsible for suppressing p21 induction 
and subsequent senescence [104,105]. Th  e  gene  ID1 has 
been shown to repress HRAS-mediated senescence in 
the presence of increased amounts of p21 [106], arguing 
the other way. Recently, a publication showed that the 
matricellular protein CCN1, which is expressed at the 
sites of wounds, induces senescence through p53 and 
actually helps to prevent ﬁ   brosis during tissue repair 
[107]. In this case, however, the healing is tissue repair 
with scarring and not blastema-induced scarless re-
genera tion.  Th  us, the connection between senescence 
and regeneration, and its diﬀ  erence compared to onco-
genesis, is yet to be determined.
Another major regulator of p21 is transforming growth 
factor (TGF)-β1, which is involved in anti-proliferation 
and diﬀ  erentiation [108]. TGF-β1 controls proliferation, 
diﬀ   erentiation, migration, and apoptosis in embryonic 
and adult tissue through the Smad3 pathway [109-113]. 
Multiple studies in mutant mice lacking the TGF-β1/
Smad3 pathway have implicated a regeneration pheno-
type in mice: mice lacking TGF-β1 show an increase in 
wound closure and epithelialization [114]; transgenic 
mice null for Smad3 show increased re-epithelialization 
and tissue renewal [115]; and Smad7 over-expression 
leads to Smad3 down-regulation and to enhanced liver 
regeneration through the TGF-β/Smad3/p21 pathway 
[116]. Smad3 has been implicated as a candidate gene in 
our genetic mapping studies of healer MRL and parental 
LG mice [15]. Contrary to these results, other transgenic 
studies on TGF-β1-null mice showed malfunctions in the 
repair of excisional back skin wounds due to altered 
inﬂ   ammatory responses [117-119]. Our studies have 
shown that a TGF-β1/Rag1 double knockout mouse is a 
partial healer [73]. An interesting fact is that TGF-β1 
enhances Sma-1 production and myoﬁ  broblasts 
associated with scarring [120] and reduces regenerative 
healing, whereas the TGF-β isoform TGF-β3 enhances 
scar-free healing [121].
Conclusions
Th  e MRL mouse is the ﬁ  rst genetically dissectible and 
molecularly tractable mammalian model of regeneration 
of multiple tissues in a single organism. It establishes the 
fact that regenerative capacity has not been lost to 
mammals through evolution but remains as a cryptic 
trait, which can be activated by the deletion of a single 
gene, p21. Th   us, the p21-null mouse now should become 
a ‘single gene’ standard model for mammalian regenera-
tive studies.
Th  e lack of p21 may act to enhance the regenerative 
response in various ways. It could alter DNA damage and 
checkpoint responses, leading to enhanced proliferation. 
It could reduce TGF-β signaling, leading to reduced scar 
formation, and alter diﬀ  erentiation patterns. It could lead 
to lack of senescence and reduced cytokine responses. It 
could support progenitor cell stability as seen in induced 
pluripotent stem cell formation.
Besides determining exactly which function of p21 and 
its absence is responsible for enhanced ear hole closure, it 
will also be important to deﬁ  ne the critical pathways in 
the MRL mouse that actually lead to p21 down-regulation 
and regeneration.
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